Skip to main content

AstraZeneca Lung Cancer Trial Disappoints, Sending Shares Lower

#Breaking #News #USA
AstraZeneca Lung Cancer Trial Disappoints, Sending Shares Lower

#Business Day
By @PRASHANT S. RAO from NYT
The hotly anticipated treatment had been expected to be a crucial driver of growth as the company faces more competition from generic pharmaceutical manufacturers.
http://ift.tt/2w2lX62

Comments

Popular posts from this blog